Cabral RGA, Rodríguez LFJ, Cárdenas CV, Beltrán SD, Blanco BEE, García EC

Language: Spanish
References: 23
Page: 42-46
PDF size: 354.97 Kb.

ABSTRACT

Mucormycosis is an opportunistic and angioinvasive fungal infection caused by mucoral fungi, infection can be acute or chronic.
Clinical case. A 47-year-old male patient with a history of type 2 diabetes with poor treatment adherence. He had localized stabbing pain in the nasal region, accompanied by fever, nasal congestion and frontal headache of one month of evolution. A biopsy of the nasal septum with hematoxylin-eosin was performed and necrotic bone tissue was reported with the presence of non-septate branching hyphae at 90° angles compatible with mucormycosis. In culture was growth for Rhizomucor spp.
Conclusions. Isolated chronic mucormycosis in the nasal sinuses is rare, so in cases of persistent nasal congestion or facial/ocular pain associated with risk factors and without a clear cause, mucormycosis should be investigated.

REFERENCES

1. Skiada, A., Pavleas, I. y Drogari-Apiranthitou, M., “Epidemiologyand diagnosis of mucormycosis: an update”, JFungi (Basilea), 2020, 6 (4): 265.

2. Prakash, H. y Chakrabarti, A., “Global epidemiology ofmucormicosis”, J Fungi (Basilea), 2019, 5 (1): 26.

3. Gutiérrez-Delgado, E.M., Treviño-González, J.L., Montemayor-Alatorre, A., Ceceñas-Falcón, L.A., Ruiz-Holguín,E., Andrade-Vázquez, C.J. et al., “Chronic rhino-orbito-cerebral mucormycosis: a case report and review ofthe literature”, Ann Med Surg (Londres), 2016, 6: 87-91.

4. Jeong, W., Keighley, C., Wolfe, R., Lee, W.L., Slavin,M.A., Kong, D.C.M. et al., “The epidemiology and clinicalmanifestations of mucormycosis: a systematic reviewand meta-analysis of case reports”, Clin MicrobiolInfect, 2019, 25 (1): 26-34.

5. Razem, B., Dennai, Y. y Slimani, F., “Chronical rhino-orbitalmucormycosis in an immunocompetent host: a casereport”, Int J Surg Case Rep, 2021, 82: 105882.

6. Parra Fariñas, R., Alonso-Sardón, M., Velasco-Tirado,V., Pérez, I.G., Carbonell, C., Álvarez Artero, E. et al.,“Increasing incidence of mucormycosis in Spanishinpatients from 1997 to 2018”, Mycoses, 2022, 65 (3):344-353.

7. Dusart, A., Duprez, T., Van Snick, S., Godfraind, C. ySindic, C., “Fatal rhinocerebral mucormycosis with intracavernouscarotid aneurysm and thrombosis: a latecomplication of transsphenoidal surgery?”, Acta NeurolBelg, 2013, 113 (2): 179-184.

8. Ibrahim, A.S. y Kontoyiannis, D.P., “Update on mucormycosispathogenesis”, Curr Opin Infect Dis, 2013, 26(6): 508-515.

9. Jung, H. y Park, S.K., “Indolent mucormycosis of theparanasal sinus in immunocompetent patients: are antifungaldrugs needed?”, J Laryngol Otol, 2013, 127 (9):872-875.

10. Talmi, Y.P., Goldschmied-Reouven, A., Bakon, M., Barshack,I., Wolf, M., Horowitz, Z. et al., “Rhino-orbital andrhino-orbito-cerebral mucormicosis”, Otolaryngol HeadNeck Surg, 2002, 127 (1): 22-31.

11. Hassan, M.I.A. y Voigt, K., “Pathogenicity patterns ofmucormycosis: epidemiology, interaction with immunecells and virulence factors”, Med Mycol, 2019, 57 (Supplement_2): s245-s256.

12. Harrill, W.C., Stewart, M.G., Lee, A.G. y Cernoch, P.,“Chronic rhinocerebral mucormicosis”, Laryngoscope,1996, 106 (10): 1292-1297.

13. Gupta, S., Mehrotra, A., Attri, G., Pal, L., Jaiswal, A.K. yKumar, R., “Isolated intraventricular chronic mucormycosisin an immunocompetent infant: a rare case withreview of the literature”, World Neurosurg, 2019, 130:206-210.

14. Anand, V.K., Alemar, G. y Griswold, J.A. Jr., “Intracranialcomplications of mucormycosis: an experimental modeland clinical review”, Laryngoscope, 1992, 102 (6):656-662.

15. Celis-Aguilar, E., Burgos-Páez, A., Villanueva-Ramos, N.,Solórzano-Barrón, J., De la Mora-Fernández, A., Manjarrez-Velázquez, J. et al., “An emergent entity: indolentmucormycosis of the paranasal sinuses. A multicenterstudy”, Int Arch Otorhinolaryngol, 2019, 23 (1): 92-100.

16. Kaygusuz, A., Haksever, M., Akduman, D., Aslan, S. ySayar, Z., “Sinonasal anatomical variations: their relationshipwith chronic rhinosinusitis and effect on theseverity of disease: a computerized tomography assistedanatomical and clinical study”, Indian J OtolaryngolHead Neck Surg, 2014, 66 (3): 260-266.

17. Scharf, J.L. y Soliman, A.M., “Chronic rhizopus invasivefungal rhinosinusitis in an immunocompetent host”,Laryngoscope, 2004, 114 (9): 1533-1535.

18. Cornely, O.A., Alastruey-Izquierdo, A., Arenz, D., Chen,S.C.A., Dannaoui, E., Hochhegger, B. et al., “Globalguideline for the diagnosis and management of mucormycosis:an initiative of the European Confederationof Medical Mycology in cooperation with the MycosesStudy Group Education and Research Consortium”, LancetInfect Dis, 2019, 19 (12): e405-e421.

19. Abu El-Naaj, I., Leiser, Y., Wolff, A. y Peled, M., “Thesurgical management of rhinocerebral mucormicosis”,J Craniomaxillofac Surg, 2013, 41 (4): 291-295.

20. Corzo-León, D.E., Chora-Hernández, L.D., Rodríguez-Zulueta,A.P. y Walsh, T.J., “Diabetes mellitus as the majorrisk factor for mucormycosis in Mexico: epidemiology,diagnosis, and outcomes of reported cases”, Med Mycol,2018, 56 (1): 29-43.

21. Selvamani, M., Donoghue, M., Bharani, S. y Madhushankari,G.S., “Mucormycosis causing maxillary osteomyelitis”,J Nat Sci Biol Med, 2015, 6 (2): 456-459.

22. Hemashettar, B.M., Patil, R.N., O’Donnell, K., Chaturvedi,V., Ren, P. y Padhye, A.A., “Chronic rhinofacial mucormycosiscaused by Mucor irregularis (Rhizomucorvariabilis) in India”, J Clin Microbiol, 2011, 49 (6): 2372-2375.

23. Disponible en: https://www.who.int/india/emergencies/coronavirus-disease-(covid-19)/mucormycosis).